---
figid: PMC11254102__ijmm-54-03-05397-g08
figtitle: Hypothesized molecular mechanism depicting how SalusinA ameliorates lipid
  metabolism disorders via regulation of the LKB1/AMPK signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11254102
filename: ijmm-54-03-05397-g08.jpg
figlink: /pmc/articles/PMC11254102/figure/F9
number: F9
caption: Hypothesized molecular mechanism depicting how Salusin-α ameliorates lipid
  metabolism disorders via regulation of the LKB1/AMPK signaling pathway. Salusinα
  was overexpresses or knocked down using lentiviruses. Salusin-α upregulated LKB1
  expression and thus activated AMPK, which resulted in a decrease in the downstream
  SREBP-1c/FASN/ACC levels, thus reducing the severity of NAFLD. AS and NAFLD are
  causative factors in the deterioration of the other respective disease, and the
  elevated levels of LDLs in blood vessels leads to an increase in fatty acid content
  and worsens the degree of NAFLD. Gray arrows indicate the mechanistic process by
  which lentiviral vectors transport and regulate Salusin-α expression. Red arrows
  indicate changes in the expression of signaling pathway molecules following overexpression
  of Salusin-α in HepG2 cells, and green arrows indicate the changes in intravascular
  lipoprotein during the development of AS. LKB1, liver kinase B1; AMPK, adenosine
  5′-monophosphate (AMP)-activated protein kinase; NAFLD, non-alcoholic fatty liver
  disease; FASN, fatty acid synthase; ACC, acetyl-CoA carboxylase; AS, atherosclerosis;
  LDL, low density lipoprotein; VLDL, very low-density lipoprotein; HDL, high-density
  lipoprotein; ROS, reactive oxygen species; SREBP-1c, sterol regulatory element binding
  protein-1c; ER, endoplasmic reticulum; p-, phosphorylated
papertitle: Salusin-α alleviates lipid metabolism disorders via regulation of the
  downstream lipogenesis genes through the LKB1/AMPK pathway
reftext: Jintong Pan, et al. Int J Mol Med. 2024 Sep;54(3).
year: '2024'
doi: 10.3892/ijmm.2024.5397
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords: salusin-α | lipid metabolism disorders | LKB1 | AMPK | SREBP-1c | HepG2
automl_pathway: 0.9518781
figid_alias: PMC11254102__F9
figtype: Figure
redirect_from: /figures/PMC11254102__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11254102__ijmm-54-03-05397-g08.html
  '@type': Dataset
  description: Hypothesized molecular mechanism depicting how Salusin-α ameliorates
    lipid metabolism disorders via regulation of the LKB1/AMPK signaling pathway.
    Salusinα was overexpresses or knocked down using lentiviruses. Salusin-α upregulated
    LKB1 expression and thus activated AMPK, which resulted in a decrease in the downstream
    SREBP-1c/FASN/ACC levels, thus reducing the severity of NAFLD. AS and NAFLD are
    causative factors in the deterioration of the other respective disease, and the
    elevated levels of LDLs in blood vessels leads to an increase in fatty acid content
    and worsens the degree of NAFLD. Gray arrows indicate the mechanistic process
    by which lentiviral vectors transport and regulate Salusin-α expression. Red arrows
    indicate changes in the expression of signaling pathway molecules following overexpression
    of Salusin-α in HepG2 cells, and green arrows indicate the changes in intravascular
    lipoprotein during the development of AS. LKB1, liver kinase B1; AMPK, adenosine
    5′-monophosphate (AMP)-activated protein kinase; NAFLD, non-alcoholic fatty liver
    disease; FASN, fatty acid synthase; ACC, acetyl-CoA carboxylase; AS, atherosclerosis;
    LDL, low density lipoprotein; VLDL, very low-density lipoprotein; HDL, high-density
    lipoprotein; ROS, reactive oxygen species; SREBP-1c, sterol regulatory element
    binding protein-1c; ER, endoplasmic reticulum; p-, phosphorylated
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STK11
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - FASN
  - HSD11B1
  - ALB
  - APOA1
  - APOA2
  - APOE
  - CLU
  - Fatty acids
  - LDL
  - VLDL
  - HDL
  - Atherosclerosis
---
